Collectively, these studies suggest that obesity-associated variants of FTO regulate the expression of IRX3 and IRX5 in the hypothalamus and adipose tissue contributing to metabolic changes. The gene discussed is IRX5; the disease is obesity due to melanocortin 4 receptor deficiency.